Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Fresenius Medical Care Corp (FMS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,498,268
  • Shares Outstanding, K 613,692
  • Annual Sales, $ 19,542 M
  • Annual Income, $ 2,341 M
  • 60-Month Beta 1.40
  • Price/Sales 1.22
  • Price/Cash Flow 10.52
  • Price/Book 1.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.55
  • Number of Estimates 1
  • High Estimate 0.55
  • Low Estimate 0.55
  • Prior Year 0.54
  • Growth Rate Est. (year over year) +1.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.59 +2.85%
on 05/20/19
42.75 -9.57%
on 05/03/19
-0.71 (-1.80%)
since 04/18/19
3-Month
37.13 +4.12%
on 03/08/19
42.75 -9.57%
on 05/03/19
-1.19 (-2.99%)
since 02/21/19
52-Week
30.99 +24.75%
on 01/03/19
53.40 -27.60%
on 08/29/18
-12.55 (-24.51%)
since 05/21/18

Most Recent Stories

More News
Recent Analysis Shows Fresenius Medical Care AG & Co. KGaA, OFS Capital, Westell Technologies, and Ranger Energy Services Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fresenius Medical Care AG &...

RNGR : 6.88 (-1.01%)
WSTL : 2.10 (+2.44%)
FMS : 38.66 (+0.97%)
OFS : 12.34 (+0.90%)
Fresenius Medical (FMS) Q1 Earnings & Revenues Top Estimates

Fresenius Medical (FMS) gains from solid international revenues in Q1.

ABT : 76.03 (+0.34%)
SYK : 185.45 (+0.62%)
FMS : 38.66 (+0.97%)
CNMD : 80.65 (+0.79%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS

Pomerantz LLP is investigating claims on behalf of investors of Fresenius Medical Care AG & Co. KGaA ("Fresenius" or the "Company") (NYSE: FMS). Such investors are advised to contact Robert S. Willoughby...

FMS : 38.66 (+0.97%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS

Pomerantz LLP is investigating claims on behalf of investors of Fresenius Medical Care AG & Co. KGaA ("Fresenius" or the "Company") (NYSE: FMS). Such investors are advised to contact Robert S. Willoughby...

FMS : 38.66 (+0.97%)
Fresenius Medical to Make Huge Investments, Competition Rife

Fresenius Medical (FMS) is likely to make huge investments in India and China.

VAR : 127.94 (-1.97%)
MASI : 138.93 (+0.31%)
FMS : 38.66 (+0.97%)
DXCM : 118.59 (+0.10%)
Fresenius Medical's New Hemodialysis Software Gets FDA Nod

Fresenius Medical (FMS) offers a wide range of HD and PD dialysis products.

VEEV : 143.11 (+1.74%)
BAX : 75.30 (-0.03%)
FMS : 38.66 (+0.97%)
DVA : 49.60 (+1.49%)
Baxter's (BAX) New Tie Up to Boost Acute Therapies Business

Baxter's (BAX) Acute Therapies business is expected to grow 7-8% in 2019.

VEEV : 143.11 (+1.74%)
BAX : 75.30 (-0.03%)
FMS : 38.66 (+0.97%)
DVA : 49.60 (+1.49%)
Should Value Investors Pick Fresenius Medical (FMS) Stock?

Let's see if Fresenius Medical (FMS) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

FMS : 38.66 (+0.97%)
Fresenius Medical (FMS) Earnings Beat, Revenues Miss in Q4

Fresenius Medical (FMS) sees higher Q4 revenues in EMEA and Asia Pacific regions.

VAR : 127.94 (-1.97%)
ANGO : 19.08 (-1.24%)
FMS : 38.66 (+0.97%)
CNMD : 80.65 (+0.79%)
Fresenius Medical Care completes acquisition of NxStage Medical

Fresenius Medical Care, the world's largest provider of dialysis products and services, has successfully completed the acquisition of NxStage Medical, Inc. (NxStage), following approval by antitrust authorities...

NXTM : 30.00 (+0.03%)
FMS : 38.66 (+0.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade FMS with:

Business Summary

Fresenius Medical Care provides a range of products for both treatment modalities, hemmodialysis and peritoneal dialysis, and is a full service provider of dialysis care. They provide dialysis treatment and related laboratory and diagnostic services at more than 1,000 dialysis clinics. They manufacture...

See More

Key Turning Points

2nd Resistance Point 38.97
1st Resistance Point 38.82
Last Price 38.66
1st Support Level 38.43
2nd Support Level 38.19

See More

52-Week High 53.40
Fibonacci 61.8% 44.84
Fibonacci 50% 42.19
Fibonacci 38.2% 39.55
Last Price 38.66
52-Week Low 30.99

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar